PharmExec Picks:
Having trouble viewing this e-mail? Click here.
feed back

Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE


Pharm Exec Picks is a biweekly eletter that delivers the most popular news and articles from the pharma space and highlights what's trending on social media.

Top 5 Stories :
2015 Pipeline Report: Burning Bright
This year's pipeline report will check in on emerging technologies, as well as potential therapies to address metabolic and neurodegenerative diseases. There's a lot to like in the pipeline and more than a little competitive drama to make it really interesting.
Read more
Sales Reps and the New Commercial Organization
By rethinking the role of the sales rep and the new skills it demands—and then executing boldly around a new customer-driven master plan—pharma companies can put themselves in a prime competitive position.
Read more
Managed Markets: Positioning Your Product For Success with Pull Through Strategies
By driving physician prescribing away from more costly and more restricted drugs, pharmaceutical company-initiated Pull Through programs can increase market share while lowering the overall cost of the medication to the payer, employer and ultimately even the patient.
Read more
"Sunshine" Policy Continues To Exempt CME Funding
CME supporters still would like Congress to codify that indirect CME funding is exempt from Sunshine reporting, and extend that policy to reporting on the value of educational materials, such as textbooks, which CMS continues to consider payments to physicians.
Read more
Top 10 Medical Innovations for 2015
The Cleveland Clinic once again ended its Medical Innovation Summit with a list of 10 advances voted most likely to have a major impact on improving patient care in 2015.
Read more
Trending on Social Media :
Industry Growth Slowdown in Brazil
The Brazilian economy is being impacted by internal and external factors, and forecast figures are being quickly revised downwards.
Read more
Germany Post AMNOG
While emerging markets continue to represent a new channel of demand for pharmaceutical products, manufacturers have quickly realized that significant attention must still be given to more established markets, such as Germany.
Read more
Health 2.0 2014: Infrastructure Gets Sexy, HCP Apps Steal the Show
Bill Drummy shares his impressions of two of the industry’s best-known and most influential conferences. To compress the contrast between them to a single sentence: TEDMED is all about inspiration and high-minded theory, while Health 2.0 is all about pragmatism and practice.
Read more
Follow Us